Cannabis Professional’s daily roundup of industry news. View archive here.
Canopy appoints new board chair, board member
Canopy Growth Corp. has appointed a new chair for its board of directors and added another member to the board, the company said Wednesday. Judy Schmeling will take over as chairman — a position recently vacated by David Klein, who became Canopy’s CEO in December.
Ms. Schmeling has been on Canopy’s board since November 2018, and she also sits on the board of Canopy’s main backer, Constellation Brand Inc. as well as on the board of Casey’s General Stores. She is the former chief operating officer of online retailer HSN Inc.
Jim Sabia, another Constellation executive, has also joined Canopy’s board. Mr. Sabia currently serves as Constellation’s chief marketing officer, and was previously vice president of marketing and media at Molson Coors Brewing Co.
“Mr. Sabia will act as an observer to the board as he and Canopy complete the standard Health Canada processes associated with the appointment,” Canopy said in a statement.
– Mark Rendell
Second Aphria facility receives EU GMP certification
A second Aphria Inc. facility has received European Union Good Manufacturing Practices (EU GMP) certification. The company’s Aphria One facility in Leamington, Ont. has been certified by Malta’s health authority as “an active substance manufacturer,” the company said on Wednesday.
The announcement comes a day after Aphria announced that its subsidiary ARA - Avanti Rx Analytics received EU GMP certification. Having EU GMP certification is a prerequisite for shipping cannabis to most European Union countries.
“The certification will allow the Company’s Aphria One facility to be a supplier of bulk dried flower for medicinal use worldwide to other EU GMP certified facilities licensed to further process or package bulk dried flower into finished cannabis product for sale in permitted jurisdictions,” Aphria said in a statement.
- Mark Rendell